会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • 1,4-dihydropyridine derivatives
    • 1,4-二氢吡啶衍生物
    • US5286869A
    • 1994-02-15
    • US492951
    • 1990-03-12
    • Hiroshi IkawaAkiyoshi KadoiriYasuo Sekine
    • Hiroshi IkawaAkiyoshi KadoiriYasuo Sekine
    • C07D401/12
    • C07D401/12
    • 1,4-Dihydropyridine derivatives of formula: ##STR1## wherein Ar.sup.1 represents an aromatic hydrocarbon group or an aromatic heteromonocyclic or heterobicyclic group containing therein 1 to 3 atoms selected from the group consisting of oxygen, sulfur and nitrogen; R.sup.1 represents a hydrocarbon group which may have one or more substituents; A represents (i) a straight chain or branched chain unsaturated hydrocarbon group, (ii) a cyclic unsaturated hydrocarbon group, or (iii) a group selected from the group consisting of --R--O--N.dbd.CH--, --R--N.dbd.N--, --R--CH.dbd.N-- and --R--N.dbd.CH--, in which R is an alkylene group having 1 to 6 carbon atoms; B represents an alkylene or alkenylene group having 1 to 3 carbon atoms, which may have a substituent; Ar.sup.2 represents an aromatic hydrocarbon group or a heterocyclic group; Ar.sup.3 represents a heterocyclic group which may have one or more substituents; and n is 0 or 1, and the corresponding optical active 1,4-dihydropyridine derivatives, having an optically active cite as indicated by *, have both superior vasodilative and platelet aggregation inhibiting activities.
    • 其中Ar 1表示芳族烃基或含有选自氧,硫和氮的1至3个原子的芳族杂单环或杂双环基; R1表示可具有一个或多个取代基的烃基; A表示(i)直链或支链不饱和烃基,(ii)环状不饱和烃基,或(iii)选自-RON = CH-,-RN = N-,-R -CH = N-和-RN = CH-,其中R是具有1至6个碳原子的亚烷基; B表示可以具有取代基的碳原子数1〜3的亚烷基或亚烯基; Ar 2表示芳香族烃基或杂环基; Ar 3表示可以具有一个以上取代基的杂环基; 并且n为0或1,并且具有如*所示的光学活性引物的相应的光学活性1,4-二氢吡啶衍生物具有优异的血管扩张和血小板聚集抑制活性。